Million-Person study links ancient chinese medicine to modern disease prevention
NCT ID NCT07196917
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow one million adults in China aged 30 to 74 for up to 10 years. Researchers will collect health data and Traditional Chinese Medicine (TCM) body type information to see how they relate to chronic diseases like heart disease, diabetes, and cancer. The goal is to develop better ways to prevent and manage these conditions by combining TCM and Western medicine.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help create personalized health strategies combining Traditional Chinese and Western medicine for early disease detection and prevention.
- What could go wrong
- This is an observational study, not a treatment trial. It will collect data but may not directly lead to new therapies. Results depend on long-term follow-up and accurate reporting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000,000 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Oct 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Targeting urban and rural residents across multiple regions in Hubei Province, this study plans to recruit 1 million participants. Standardized protocols will be employed for baseline questionnaire surveys, physical examinations, and biological sample collection.
- Ages
-
30 to 74 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Age: Participants aged 30 to 74 years Physical Functionality: Free from severe physical disabilities impacting mobility or communication, with preserved ability to comprehend and respond to study procedures Informed Consent: Capable of providing written informed consent voluntarily after receiving full study disclosure Exclusion Criteria: Residents living in functional areas (e.g., work sheds, military units, student dormitories, nursing homes, etc.) Individuals unable to communicate normally
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a gentler blood thinner shield cancer patients from new clots?
- Could monthly texts and automatic risk scores stop heart attacks before they start?
- Can more phone calls after cancer surgery keep patients out of the hospital?
- Live music meets virtual reality: can a Three-Session program reach advanced cancer patients in palliative care?
- Matching cancer survivors to the right level of support